Correlation between Epstein Barr virus antibodies, serum IgE and atopic disease

Pediatric Allergy and Immunology

Volumn 8, Issue 2, 1997, Pages 91-96

  Calvani, Mauro ^a,b   Alessandri, Claudia ^a   Paolone, Giuseppe ^a   Rosengard, Luciano ^a   Di Caro, Antonino ^a   De Franco, David ^b  

^a SAN CAMILLO DE LELLIS HOSPITAL   (Italy)

^b NONE   (Italy)

Author keywords

Atopic disease; Atopic hypersensitivity; Epstein Barr virus

Indexed keywords

IMMUNOGLOBULIN E; VIRUS ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; ATOPY; CHILD; EPSTEIN BARR VIRUS; FEMALE; HUMAN; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN BLOOD LEVEL; INFANT; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SERODIAGNOSIS; SYMPTOM; VIRUS INFECTION;

EID: 0030731651     PISSN: 09056157     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3038.1997.tb00150.x     Document Type: Article

References (43)

1. BJORKSTÉN B. Risk factors in early childhood for the development of atopic diseases. Allergy 1994: 49: 400-7.
2. BUSSE WW. The relationship between viral infections and onset of allergic disease and asthma. Clin Exp Allergy 1989: 19: 1-9.
3. RYSTEDT I, STRANNEGARD IL, STRANNEGARD O. Increased serum levels of antibodies to Epstein Barr virus in adults with history of atopic dermatitis. Int Arch Allergy Appl Immunol 1984: 75: 179-83.
4. MAGNUSSEN H, JORRES R, NOVAK D. Effect of air pollution on the prevalence of asthma and allergy: lessons from the German unification. Thorax 1993: 48: 879-81.
5. VON MUTIUS E, MARTINEZ FD, FRITZSCH C, et al. Prevalence of asthma and atopy in two areas of West and East Germany. Am J Respir Crit Care Med 1994: 149: 358-64.
6. CALVANI M JR, ZANIRATTI MS. EBV Infection in childhood. Clinical, epidemiological and immunological aspects in children under three years of age. Riv Ital Pediatr (IJP) 1992: 18: 535-43.
7. WOODHEAD H, ADDISON G, HALES C. The immunoradiometric assay and related techniques. Br Med Bull 1974: 30: 44-9.
8. CAVAGNI G, CAPRA T, SUZZANI L, NORI G, LAPETINA F, DERIU FM, et al. Valori di IgE in bambini sani, non atopici. Folia Allergol Immunol Clin 1980: 27: 273-6.
9. DEAN J, DEAN A, BURTON A, DICKER R. Epi Info Version 5.01a. Centers for Disease Control, Atlanta, GA 30333, March 1991.
10. BARBEE RA, HALONEN M, LEBOWITZ M, BURROWS B. Distribution of IgE in a community population sample, correlation with age, sex and allergen skin test reactivity. J Allergy Clin Immunol 1981: 68: 106-10.
11. BUSSE WW. The relationship between viral infections and onset of allergic diseases, and asthma. Clin Exp Allergy 1989: 19: 1-9.
12. PATTEMORE PK, JOHNSTON SL, BARDIN PG. Viruses as precipitants of asthma symptoms. I Epidemiology. Clin Exp Allergy 1992: 22, 325-36.
13. STARK JM, BUSSE WW. Respiratory virus infection and airway hyperreactivity in children. Pediatr Allergy Immunol 1991: 2: 95-110.
14. SUMAYA CV. Infectious mononucleosis in children. In: MOSS AJ, ed: "Pediatrics Update. Review for physicians", 1985: 12-31.
15. JONES JF. A perspective of Epstein Barr virus disease. Adv Pediatr 1989: 36: 307-46.
16. FRICK OL, BROOKS DL. Immunoglobulin E antibodies to pollens augmented in dogs by virus vaccines. Am J Vet Res 1983: 44: 440-4.
17. FRICK OL. Effect of respiratory and other virus infections on IgE immunoregulation. J Allergy Clin Immunol 1986: 78: 1013-18.
18. SAKAMOTO M, IDA S, TAKISHIMA T. Effect of influenza virus infection on allergic sensitization to aerosolized ovalbumin in mice. J Immunol 1984: 132: 2614-17.
19. FRICK OL, GERMAN DF, MILLS J. Development of allergy in children. Association with virus infection. J Allergy Clin Immunol 1979: 63: 228-41.
20. HOLT PG. Environmental factors and primary T-cell sensitization to inhalant allergens in infancy: reappraisal of the role of infections and air pollution. Pediatr Allergy Immunol 1995: 6: 1-10.
21. BRABACK L, BREBORWICZ A, DREBORG S, et al. Atopic sensitisation and respiratory symptoms among Polish and Swedish school children. Clin Exp Allergy 1994: 24: 826-35.
22. WILLIES-JACOBO LJ, DENSON-LINO JM, ROSAS A, et al. Socioeconomic status and allergy in children with asthma. J Allergy Clin Immunol 1993: 92: 630-2.
23. SHAHEEN SO. Changing patterns of childhood infection and the rise in allergic disease. Clin Exp Allergy 1995: 25: 1034-7.
24. SUMAYA CV. Epstein Barr virus infections in children. Curr Probl Pediatr 1987: 17: 677-745.
25. SCHUSTER V, KRETH HW. Epstein Barr virus infection and associated diseases in children. Eur J Pediatr 1992: 151: 718-25.
26. FINGEROTH JD, WEIS JJ, TEDDER RF, et al. Epstein Barr virus receptor of human B lymphocytes is the C3d receptor CRC. Proc Natl Acad Sci USA 1984: 81: 4510-4.
27. AUBRY J-P, POCHON S, GRABER P, JANSEN K, BONNEFOY J-Y. CD21 is a ligand for Cd23 and regulates IgE production . Nature 1992: 358: 505-7.
28. FLORES-ROMO L, SHIELDS J, HUMBERT Y et al. Inhibition of an in vivo antigen-specific IgE response by antibodies to CD23. Science 1993: 261: 1038.
29. HENCHOZ-LECOANET S, JEANNIN P, AUBRY J-P, GRABER P, BRADSHAW CG, POCHON S, et al. The Epstein-Barr virus-binding site on CD21 is involved in CD23 binding and interleukin-4-induced IgE and IgG4 production by human B cells. Immunology 1996: 88: 35-9.
30. VERCELLI D, JABARA HH, ARAI K, GEHA RS. Induction of human IgE synthesis requires interleukin-4 and T/B cell interactions involving the T-Cell receptor/Cd3 complex and MHC class II antigens. J Exp Med 1989: 169: 1295-307.
31. GAUCHAT J-F, LEBMAN DA, COFFMAN RL, GASCAN H, DE VRIES JE. Structure and expression of germline E transcripts in human B-cells induced by interleukin 4 to switch to IgE production. J Exp Med 1990: 172: 463-73.
32. VERCELLI D. Immunoglobulin E regulation in humans, 1989-1994. Allergy 1995: 50: 5-8.
33. JABARA HH, SCHNEIDER LC, SHAPIRA SK. ALFIERI C, MOODY CT, KIEFF E, et al. Induction of germ line and mature Ce transcripts in human B cells stimulated with r-II4 and EBV. J Immunol 1990: 145: 3468-73.
34. NORDBRING F, JOHANSSON SGO, ESPMARK A. Raised serum levels of IgE in infectious mononucleosis. Scand J Infect Dis 1972: 4: 119-24.
35. BAHNA SL, HORWITZ CA, FIALA M, HEINER DC. IgE response in heterophil-positive infectious mononucleosis. J Allergy Clin Immunol 1978: 62: 167-73.
36. PRABHU A, WARWICK M, MATHUR A. Decreased levels of circulating IFN-A and increased sCD23 in patients with acute infectious mononucleosis. Viral Immunol 1996: 9: 45-50.
37. OLSON GB, KANAAN MN, GERSUK GM, KELLEY LM, JONES JF. Correlation between allergy and persistent Epstein B arr virus infections in chronic active Epstein Barr virus infected patients. J Allergy Clin Immunol 1986: 78: 308-14.
38. STRANNEGARD IL, STRANNEGARD O. Epstein Barr virus antibodies in children with atopic disease. Int Arch Allergy Appl Immunol 1981: 64: 314-19.
39. SCHUSTER V, HEROLD M, WACHTER H, REIBNEGGER G. Serum concentration of interferon gamma, interleukin-6 and neopterin in patients with infectious mononucleosis and other Epstein-Barr virus-related lymphoproliferative diseases. Infection 1993: 21; 210-13.
40. VIRELIZIER JL, LENOIR G, GRISCELLI C. Persistent EpsteinBarr virus infection in a child with hypergammaglobulinaemia and immunoblastic proliferation associated with a defect in immune interferon secretion. Lancet 1978: ii; 231-4.
41. LILJA G, ÖMAN H. Prediction of atopic disease in infancy by determination of immunological parameters: IgE, IgE- and IgG- antibodies to food allergies, skin prick testing and T-lymphocyte subsets. Pediatr Allergy Immunol 1991: 2: 6-10.
42. KJELLMAN NIM. Predictive value of high IgE levels in children. Acta Paediatr Scand 1976: 65: 465-9.
43. MUDDE GC, BHEEKHA R, BRUIJNZEEL-KOOMEN CAFM. IgE mediated antigen presentation. Allergy 1995: 50: 193-9.